Page 90 - Critical Care Notes
P. 90

4223_Tab02_045-106  29/08/14  10:00 AM  Page 84



                  CV
          ■ Consider antiarrhythmics (given without interrupting CPR):
            ■ Amiodarone: 300 mg IV or IO, may repeat 150 mg in 3–5 min.
            ■ Lidocaine: 1.0–1.5 mg/kg IV or IO, may repeat 0.5–0.75 mg/kg q5–10 min,
             max 3 mg/kg.
            ■ Magnesium: 1–2 g IV or IO for torsades de pointes.
          ■ A 2011 study published in Circulation showed that patients with a shockable
            rhythm (VF or pulseless VT) had better survival rates if CPR is paused for
            only 10 sec or less before delivery of electric shock to the heart (preshock
            pause) or a total of 20 sec or less pause in chest compressions both before
            and after defibrillatory shock (perishock pause).
          ■ 76% of patients show signs of ongoing instability for several hours prior to
            cardiac arrest.
          ■ 70% of patients show signs of respiratory distress within 8 hr of arrest.
          ■ 66% of patients show abnoral signs and symptoms within 6 hr of arrest.
               Asystole or Pulseless Electrical Activity (PEA)
          ■ Resume CPR for 5 cycles (should last about 2 min).
          ■ Epinephrine: 1 mg IV or IO (2 to 2.5 mg ET) every 3–5 min or vasopressin:
            40 units IV or IO, one time only. May use to replace 1st or 2nd dose of epi-
            nephrine (given without interrupting CPR).

                    Intra-aortic Balloon Pump
                     Counterpulsation (IABP)
          IABP counterpulsation provides temporary mechanical circulatory support.
          Goals of IABP counterpulsation: increase O 2 to myocardium and coronary arteries,
          decrease LV workload by decreasing impedance to ejection (afterload), and
          increase cardiac output. An IABP device consists of a 30-cm polyurethane balloon
          attached to one end of a large-bore catheter. The device is inserted into the femoral
          artery at the groin, either percutaneously or via arteriotomy, with the balloon
          wrapped tightly around the catheter. Once inserted, the catheter is advanced up
          the aorta until the tip lies just beyond the origin of the left subclavian artery. When
          in place, the balloon wrapping is released to allow periodic balloon inflations.
                               Effects

          The intra-aortic balloon is inflated with helium at the onset of each diastolic
          period (middle of T wave), when the aortic valve closes. The balloon is deflated
          at the onset of ventricular systole, just before aortic valve opens (prior to QRS
          complex). An arterial waveform can be used as an alternative to ECG triggering.
          Inflation of the balloon increases the peak diastolic pressure and displaces
                                84
   85   86   87   88   89   90   91   92   93   94   95